01 1MYLAN LABORATORIES LIMITED
02 1Tianish Laboratories Private Limited
03 1n.v. Ajinomoto OmniChem S.A.
01 2FOSAMPRENAVIR CALCIUM
02 1Not applicable
01 1India
02 1Japan
03 1U.S.A
NDC Package Code : 50923-1014
Start Marketing Date : 2011-03-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84206-0050
Start Marketing Date : 2024-08-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-806
Start Marketing Date : 2015-01-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A FOSAMPRENAVIR CALCIUM manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of FOSAMPRENAVIR CALCIUM, including repackagers and relabelers. The FDA regulates FOSAMPRENAVIR CALCIUM manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. FOSAMPRENAVIR CALCIUM API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of FOSAMPRENAVIR CALCIUM manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A FOSAMPRENAVIR CALCIUM supplier is an individual or a company that provides FOSAMPRENAVIR CALCIUM active pharmaceutical ingredient (API) or FOSAMPRENAVIR CALCIUM finished formulations upon request. The FOSAMPRENAVIR CALCIUM suppliers may include FOSAMPRENAVIR CALCIUM API manufacturers, exporters, distributors and traders.
click here to find a list of FOSAMPRENAVIR CALCIUM suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing FOSAMPRENAVIR CALCIUM as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for FOSAMPRENAVIR CALCIUM API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture FOSAMPRENAVIR CALCIUM as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain FOSAMPRENAVIR CALCIUM and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a FOSAMPRENAVIR CALCIUM NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of FOSAMPRENAVIR CALCIUM suppliers with NDC on PharmaCompass.
We have 3 companies offering FOSAMPRENAVIR CALCIUM
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
